The impact of COVID-19 on the treatment of obsessive-compulsive disorder

被引:2
|
作者
Palo, Amanda [1 ]
D'Souza, Johann M. [2 ,3 ]
机构
[1] Baylor Coll Med, Dept Psychiat & Behav Sci, 1977 Butler Blvd,Suite 400, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Houston, Dept Psychol, Houston, TX USA
关键词
obsessive-compulsive disorder; exposure and response prevention; COVID-19; treatment; telehealth; COGNITIVE-BEHAVIORAL THERAPY; RITUAL PREVENTION; TRIAL; EXPOSURE;
D O I
10.1521/bumc_2021_85_03
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The COVID-19 pandemic has led to challenges in providing cognitive-behavioral therapy for patients with obsessive-compulsive disorder (OCD). Despite the presence of the pandemic and the risk of contracting illness, therapists can continue to utilize exposure with response prevention (ERP), which is the gold standard psychotherapy treatment for OCD. Therapists can ethically implement ERP by focusing on core treatment tenets while incorporating guidelines recommended by the Centers for Disease Control and Prevention to mitigate risk for COVID-19 exposure. The pandemic has also provided an opportunity to more widely implement ERP through virtual telehealth appointments, which have notable benefits as well as some drawbacks.
引用
收藏
页码:35 / 47
页数:13
相关论文
共 50 条
  • [41] How is the COVID-19 pandemic affecting individuals with obsessive-compulsive disorder (OCD) symptoms?
    Wheaton, Michael G.
    Ward, Haley E.
    Silber, Alana
    McIngvale, Elizabeth
    Bjorgvinsson, Throstur
    JOURNAL OF ANXIETY DISORDERS, 2021, 81
  • [42] Intentions of Clinical Social Workers for Treatment of Obsessive-Compulsive Disorder
    Smith, Amasa
    Solomon, Phyllis
    Brown, Lily A.
    RESEARCH ON SOCIAL WORK PRACTICE, 2025,
  • [43] Immediate reactions to the covid-19 pandemic in adults with obsessive-compulsive disorder: a self-report survey
    Hojgaard, Davio R. M. A.
    Duholm, Charlotte
    Nissen, Judith B.
    Jensen, Sanne
    Thomsen, Per Hove
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (08) : 582 - 589
  • [44] Individualized Intensive Treatment for Obsessive-Compulsive Disorder: A Team Approach
    Shikatani, Bethany
    Vas, Shona N.
    Goldstein, Daniel A.
    Wilkes, Chelsey M.
    Buchanan, Angel
    Sankin, Lindsey S.
    Grant, Jon E.
    COGNITIVE AND BEHAVIORAL PRACTICE, 2016, 23 (01) : 31 - 39
  • [45] The Pharmacological Treatment of Obsessive-Compulsive Disorder
    Pittenger, Christopher
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2023, 46 (01) : 107 - 119
  • [46] The psychological treatment of obsessive-compulsive disorder
    Abramowitz, Jonathan S.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2006, 51 (07): : 407 - 416
  • [47] Obsessive-Compulsive Disorder During the Initial Stage of COVID-19 Pandemic Effect of Contamination Symptoms and Poor Insight on Obsessive-Compulsive Disorder Exacerbation
    Tulaci, Riza Gokcer
    Tulaci, Ozge Demircan
    Dolapoglu, Nazan
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2022, 210 (08) : 570 - 576
  • [48] Obsessions: the impact and treatment of obsessive-compulsive disorder in children and adolescents
    Thomsen, PH
    JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (02) : S31 - S37
  • [49] What is the impact of pharmacotherapy on psychotherapy for obsessive-compulsive disorder?
    Marazziti, Donatella
    Pozza, Andrea
    Avella, Maria Teresa
    Mucci, Federico
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1651 - 1654
  • [50] The associations of obsessive-compulsive symptom dimensions and general severity with suicidal ideation in patients with obsessive-compulsive disorder: The role of specific stress responses to COVID-19
    Khosravani, Vahid
    Samimi Ardestani, Seyed Mehdi
    Sharifi Bastan, Farangis
    McKay, Dean
    Asmundson, Gordon J. G.
    CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2021, 28 (06) : 1391 - 1402